InMed Pharmaceuticals Inc.INMNASDAQ

Revenue (LTM)

$5M

+7.5% YoY

Net Income (LTM)

$-8M

-6.3% YoY

Free Cash Flow

$-8M

Revenue CAGR (5Y)

—

Marginsdeclining

FCF($0.0B)

Unprofitable

Metric	Jun 21	Jun 22	Jun 23	Jun 24	Jun 25
Revenue	0	1	4↑279.6%	5↑11.2%	5↑7.5%
Gross Profit	0	1	1↑158.1%	1↓21.5%	2↑55.0%
Operating Income	-12	-14↓13.3%	-8↑39.2%	-8↑2.9%	-8↑2.7%
Net Income	-13	-19↓47.0%	-8↑57.3%	-8↑3.4%	-8↓6.3%
EBITDA	-12	-13↓9.1%	-8↑41.4%	-7↑9.2%	-7↓2.7%
EPS Diluted	-938.91	-21350.51↓2174.0%	-86.00↑99.6%	-27.55↑68.0%	-11.44↑58.5%

Metric	Jun 21	Jun 22	Jun 23	Jun 24	Jun 25
Cash & Equivalents	9	8↓12.7%	12↑48.5%	9↓23.9%	15↑67.9%
Total Current Assets	10	12↑19.3%	15↑21.5%	12↓20.8%	18↑47.5%
Total Assets	12	16↑36.1%	19↑13.5%	16↓13.5%	21↑31.3%
Total Current Liabilities	3	4↑56.0%	3↓38.0%	3↑1.7%	3↓7.1%
Total Liabilities	3	5↑60.6%	3↓44.1%	4↑34.0%	3↓18.3%
Total Equity	9	12↑28.1%	16↑37.0%	13↓21.4%	18↑45.4%
Total Debt	0	1↑206.3%	1↓49.2%	1↑153.7%	1↓23.3%
Net Debt	-9	-7↑21.0%	-11↓62.9%	-8↑32.0%	-14↓83.6%

Metric	Jun 21	Jun 22	Jun 23	Jun 24	Jun 25
Operating Cash Flow	-10	-16↓59.2%	-7↑53.3%	-7↑4.1%	-8↓11.2%
Capital Expenditure	-0	-0↓2167.1%	-0↓313.7%	-0↑94.3%	0
Free Cash Flow	-10	-16↓59.5%	-7↑52.3%	-7↑6.0%	-8↓11.0%
Stock-Based Comp	1	1↑14.4%	0↓60.1%	0↓50.5%	0↓13.4%
Net Change in Cash	2	-1↓176.2%	3↑330.6%	-2↓185.6%	5↑292.4%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance